$HUM SEC Filings

Filed On	Filing
13 Oct 2026	8-K: Regulation FD Disclosure Investors: Lisa Stoner - Humana Investor Relations; (502) 580-2652;
09 Oct 2026	8-K: Regulation FD Disclosure Supplementary audio commentary from Humana’s President and Chief Executive Officer, Jim Rechtin, may be accessed via Humana’s Investor Relations page at https://humana.gcs-web.com/.
02 Oct 2026	Form 4: Hilzinger Kurt J, Director Granted 238 Restricted Stock Units ($91.6K)
03 Sep 2026	Form 4: Nundy Shantanu, Chief Medical Officer Received 2,549 shares as a grant or award
01 Sep 2026	8-K: Regulation FD Disclosure
31 Aug 2026	Form 3: Nundy Shantanu, Chief Medical Officer Holds 0 shares of Humana Common
04 Aug 2026	Form 4: Smith Paul John, Director Received 544 shares as a grant or award
04 Aug 2026	Form 4: Crawford Frederick John, Director Received 544 shares as a grant or award
29 Jul 2026	Form 3: Crawford Frederick John, Director Holds 21 shares of Humana Common
29 Jul 2026	Form 3: Smith Paul John, Director Holds 0 shares of Humana Common
29 Jul 2026	10-Q
29 Jul 2026	8-K: Departure/Election of Directors or Officers; Compensation
29 Jul 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
02 Jul 2026	Form 4: Hilzinger Kurt J, Director Granted 233 Restricted Stock Units ($91.4K)
24 Jun 2026	11-K
24 Jun 2026	11-K
01 Jun 2026	8-K: Regulation FD Disclosure
19 May 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
14 May 2026	SCHEDULE 13G/A
05 May 2026	Form 4: Mellet Celeste, Chief Financial Officer Disposed of 15,387 shares (Grant/Award Acquisition)

Comments